Viewing nowCombinationFritwin Tablet 40/10 mg
Telmisartan Powder 23.9% 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.

MFDS item code 201605801 · Approved 2016.09.30 · Insurance code 653403710
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with telmisartan or amlodipine. Since essential hypertension can be challenging to manage, this drug helps effectively control blood pressure and reduce the risk of complications.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older patients: The usual amlodipine dosage is recommended for older patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This drug should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious risks to the fetus. If pregnancy is confirmed, this medication should be discontinued as soon as possible. This drug should not be administered to individuals who are allergic to any of its components, pregnant or nursing women, individuals with obstructive biliary diseases, severe liver impairment, certain heart-related conditions, severe hypotension, patients in shock, post-acute myocardial infarction with unstable blood flow, and those with certain kidney diseases. Caution should be exercised when administering this drug to patients with primary aldosteronism, certain heart valve diseases, liver impairment, gastrointestinal disorders, renal artery hypertension, dialysis patients, elderly individuals, and those using specific antihypertensive medications. Dizziness and peripheral edema may occur commonly with this medication, and serious side effects such as syncope have been reported rarely. If blood pressure drops too low, the patient should be laid down, and fluid therapy may be necessary. Due to the risk of elevated potassium levels, patients with impaired renal function or heart failure should have regular blood tests. This drug may interact with other medications; therefore, patients should inform their doctor or pharmacist of any other medications being taken. Nursing mothers are advised not to take this drug. The safety and efficacy of this drug have not been established in children and adolescents under 18 years of age, and its use is not recommended. Elderly individuals may be more sensitive to this drug; therefore, initiation should be with a lower dose and adjusted gradually. In cases of overdose, symptoms such as hypotension, abnormal heart rhythm, dizziness, and acute kidney failure may occur, and immediate medical attention is required as emergency treatment may be necessary. This medication should be kept out of the reach of children and should be stored in its original packaging.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light; therefore, it should be stored in a container that protects it from light. Additionally, it should be stored at room temperature, ideally between 1°C and 30°C, avoiding extremely hot or cold conditions.
White and light gray double convex oval-shaped tablet
30 tablets/box [(10 tablets/PTP*3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.